Teva Canada recalls Biomedic Acetaminophen with Codeine owing to missing child-resistant packaging

The issue:

Teva Canada Limited, in consultation with Health Canada, is recalling one lot (#669745) of Biomedic Acetaminophen with Codeine (30 caplets with 300 mg acetaminophen and 8 mg codeine) due to missing child-resistant packaging.

Who is affected:

This product poses a risk to children who could open the bottle and ingest the bottle's contents. Codeine is not recommended for use in children under 12 years old. Codeine overdose is associated with breathing problems and potential seizures in predisposed individuals. An acetaminophen overdose can have serious health consequences including liver damage. Early signs of overdose include nausea, vomiting, lethargy and sweating. Liver damage may result in liver failure or death.

What Health Canada is doing:

Health Canada is monitoring the recall by Teva Canada Ltd. Should new information be identified, Health Canada will provide an update to Canadians.

Background:

The recalled lot was distributed in July 2014 in the provinces of British Columbia and Quebec.

SOURCE Health Canada